The global effect of CpdA and the glucocorticoids on gene expression was compared by DNA array analyses in A549 lung carcinoma and Granta-519 lymphoma cells with endogenous GR; and in prostate cancer LNCaP-GR cells stably expressing exogenous GR. This evidence concerns the gene NR3C1 and prostate carcinoma.